An Interactive Case-Based Model to Managing Diabetic Foot Ulcers: The Role of Platelet-Derived Growth Factor
An Interactive Case-Based Model to Managing Diabetic Foot Ulcers: The Role of Platelet-Derived Growth Factor
Live Webinar
Course Chair/Moderator
William Li, MD
President and Medical Director
The Angiogenesis Foundation
Cambridge, Massachusetts
Faculty
Vickie R. Driver, MS, DPM, FACFAS
Section Chief, Podiatric Surgery
Director, Limb Preservation and Research and Fellowship Program
VA New England Health Care Division
Providence, Rhode Island
Donald Miller, ScD
Senior Health Research Scientist
Associate Professor
Boston University School of Public Health
Director of Research
Center for the Assessment of Pharmaceutical Practices
Boston University
Boston, Massachusetts
Gregory Schultz, PhD
UF Research Foundation Professor
Department of Obstetrics and Gynecology
Institute for Wound Research
University of Florida
Gainesville, Florida
Intended Learners
This activity are designed for physicians, pharmacists, podiatrists, physical therapists, and nurses involved in wound healing or wound care issues.
Learning Objectives
After completing this activity, participants should be able to:
- Describe the role of platelet-derived growth factor (PDGF) in stimulating the wound healing process
- Summarize the latest safety data on adjunctive therapy based on PDGF to diabetic foot ulcer healing
- Define and employ basic tenets of proper diabetic foot wound care to optimize the effectiveness of PDGF-based adjunctive therapy
- Review case-based scenarios and discuss clinical pearls acquired from the use of PDGF-based adjunctive therapy in diabetic foot ulcer care.
Activity Overview
This satellite symposium simulcast will be presented live on May 3, 2013 during the Symposium on Advanced Wound Care Spring/ Wound Healing Society Meeting 2013.
To be eligible for documentation of credit, participants must attend a full simulcast event and complete the evaluation form. After successful completion of the evaluation form online at www.naccme.com, participants may immediately print their documentation of credit.
To be eligible for credit for the live version of this activity, completed evaluations must be submitted online by May 17th.
There is no fee associated with this activity.
For questions regarding this educational activity, please call 609-371-1137.
Hardware/Software Requirements
All educational activities are accessible via a PC (Windows 2000/XP/Vista/7) or Mac (Mac OS 10.x or later) computer with current versions of the following browsers: Internet Explorer, Mozilla Firefox, Google Chrome, or Safari. Windows Media Player or compatible alternative, sound card, and speakers are required for streamed audio. The latest version of the Adobe Flash Player is suggested (please download here) for video programs. A PDF reader is required for print publications. Please direct technical questions to webmaster@naccme.com.
Accreditation
In support of improving patient care, North American Center for Continuing Medical Education, LLC (NACCME) is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.
CME
NACCME designates this live activity for a maximum of 1 AMA PRA Category 1 Credit™.
Physicians should claim only the credit commensurate with the extent of their participation this activity.
CNE
This continuing nursing education activity awards 1.0 contact hour.
Provider approved by the California Board of Registered Nursing, Provider #13255 for 1.0
contact hour.
CPME Accreditation
North American Center for Continuing Medical Education, LLC (NACCME) is approved by the Council on Podiatric Medical Education as a sponsor of continuing education in podiatric medicine.
This program is approved for 1.0 continuing education contact hour or 0.1 CEU.
CPE Accreditation
This activity is approved for 1 contact hour (0.1 CEU) of continuing pharmacy Education (UAN 0276-0000-13-020-L01-P).
This educational activity is a knowledge-based activity.
ACPE Grievance Policy
Any participant wanting to file a grievance with respect to any aspect of a continuing pharmacy education activity accredited by NACCME may contact the Assistant Director, Accreditation Services, NACCME, in writing at 300 Rike Drive, Suite A, Millstone Township, NJ 08535. The Assistant Director, Accreditation Services will review the grievance and respond within 30 days of receiving the written statement. If the participant is unsatisfied with the response, an appeal to the Executive Director, Accreditation Services, NACCME, may be made for a second level of review.
Physical Therapists
North American Center for Continuing Medical Education, LLC (NACCME), has applied for pre-approval accreditation in California, Louisiana, Ohio, and Texas, which require preapproval.
If you practice in another state, please consult its PT board.
Independent clinical reviewer: Alan Dardik, MD, PhD, Yale University School of Medicine, New Haven, CT
Nurse planner: Susie Seaman, NP, Sharp Rees-Stealy Wound Clinic, San Diego, CA
Planning Committee
The planning committee comprises Alan Dardik, MD, PhD; William Li, MD, Vickie Driver, MS, DPM, FACFAS; Donald Miller, ScD, Gregory Schultz, PhD; Susie Seaman, NP; and Tiffney Oliver, Randy Robbin, John Savage and Holly Zeller, NACCME.
Financial Disclosure and Conflicts of Interest
According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict(s). The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.
All educational materials are reviewed for fair balance, scientific objectivity of studies reported, and levels of evidence.
Full disclosure information will be included in the educational materials.
Ms. Oliver, Mr. Robbin, Mr. Savage and Ms. Zeller have disclosed no relevant financial relationships with any commercial interests.
NACCME requires faculty to inform participants whenever off-label/unapproved uses of drugs and/or devices are discussed in their presentations.
Full off-label product and/or device information will be included in the educational materials.
Privacy Policy
NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint sponsors. NACCME and our joint sponsors will not release personally identifiable information to a third party without the individual's consent, except such information as is required for reporting purposes to the appropriate accrediting agency.
NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.
Copyright © 2013 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education. The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.
Grant Support
Supported by an educational grant from Healthpoint Biotherapeutics.
